National Director, US Treatment Site Strategy & Customer Engagement, CAR T Global Operations at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, Cell TherapyIndustries

Requirements

Bachelor’s degree in business or science; MBA preferred
10+ years’ experience in the bio-pharma industry working in US and/or Global commercial teams
Prior experience in Cell and/or Gene Therapies highly desirable
Strong leadership skills: demonstrated ability to lead other leaders, influence in a matrix organization, and drive operational rigor
Proven ability to effectively manage and develop a team
Demonstrated ability to think analytically, provide customer-oriented solutions, and manage complex cross-functional issues effectively in a fast-paced environment
Ability to lead and engage with cross-disciplinary teams
Excellent verbal and written communication

Responsibilities

Lead the development and execution of the treatment site footprint strategy with cross-functional input and alignment
Oversee treatment site onboarding and activation, collaborating with stakeholders to ensure seamless strategy execution
Oversee the internal onboarding process, proactively identifying and removing obstacles to meet deadlines and evolving customer needs
Prioritize resources to enable rapid expansion to new patient opportunities and support network growth
Continuously innovate and improve onboarding processes to deliver a best-in-class customer experience and ensure readiness for future pipeline assets
Leverage customer and market insights to inform and refine the treatment site network strategy
Foster a high-performing, inclusive, and accountable team environment, prioritizing professional development and leadership growth
Empower and influence cross-functional working groups to act with urgency on behalf of patients
Champion diversity and inclusion within the team and across stakeholder engagements
Maintain a patient-centric approach, working collaboratively to remove obstacles and deliver optimal outcomes
Ensure all onboarding processes are executed within regulatory and legal guidelines
Maintain in-depth and up-to-date knowledge of customers and marketplace, key accounts, regional market dynamics, company policies, and top competitors and their potential strategies

Skills

Key technologies and capabilities for this role

Treatment Site StrategyCustomer EngagementCell Therapy OperationsCross-Functional LeadershipStrategic PlanningTeam LeadershipApheresis OperationsMarket AccessPatient Scheduling

Questions & Answers

Common questions about this position

What benefits does Bristol Myers Squibb offer?

Bristol Myers Squibb offers a wide variety of competitive benefits, services, and programs that provide employees with resources to pursue their goals both at work and in their personal lives.

Is this role remote or does it require office presence?

This information is not specified in the job description.

What is the salary for this position?

This information is not specified in the job description.

What skills and experience are required for this role?

The role requires leadership of high-performing teams, strategic planning for treatment site expansion, cross-functional collaboration, and expertise in customer engagement and onboarding processes.

What is the company culture like at Bristol Myers Squibb?

The culture emphasizes challenging, meaningful, life-changing work with high-achieving teams, work-life balance, flexibility, professional development, diversity, inclusion, and a patient-centric approach.

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free